MED
MED
NYSE · Consumer products

Medifast Inc

$11.74
+0.03 (+0.26%)
As of Sep 29, 3:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
394.42M
Net Income
-19,089,776
Gross Margin
71.3%
Profit Margin
-4.8%
Rev Growth
-37.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.3% 71.3% 56.0% 56.0%
Operating Margin -3.7% -3.3% 16.6% 19.4%
Profit Margin -4.8% -4.6% 15.1% 16.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 394.42M 633.50M 15.63M 13.56M
Gross Profit 281.34M 451.88M 8.76M 7.60M
Operating Income -14,514,568 -20,981,547 2.60M 2.64M
Net Income -19,089,776 -27,595,243 2.36M 2.26M
Gross Margin 71.3% 71.3% 56.0% 56.0%
Operating Margin -3.7% -3.3% 16.6% 19.4%
Profit Margin -4.8% -4.6% 15.1% 16.7%
Rev Growth -37.7% -37.7% +0.8% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 67.55M 61.71M
Total Equity — — 104.54M 106.99M
D/E Ratio — — 0.65 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 29.2K 44.5K 4.67M 3.57M
Free Cash Flow — — 2.91M 2.77M